ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.

Pradipta Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.